top of page
ADDRESSING PERVASIVE TREATMENT CHALLENGES IN DERMATOLOGY
Veradermics has cultivated a dermatology-focused pipeline of five novel product candidates for large-market conditions seen in adults and children that are overdue for new treatment approaches including androgenetic alopecia (pattern hair loss), common warts (verruca vulgaris), molluscum contagiosum, alopecia areata, and atopic dermatitis.
We have a rapidly advancing diverse pipeline of first-in-class candidates
Program Indication
MOA Delivery
PRE-IND
PHASE 1
PHASE 2
PHASE 3
VDPHL
Androgenetic Alopecia
Confidential MOA
Oral
Tablet
VDMN
Common Warts
Candida Antigen Extract
Immunotherapy
Dissolvable Microarray
VDAA
Alopecia Areata
Topical
Contact
Immunotherapy
VDAD
Atopic Dermatitis
Novel
Oral
Immunomodulator
VDMC
Molluscum Contagiosum
Topical
New Chemical Entity
Antiviral
bottom of page